Therapeutics Company Announces Notice of Allowance For Major Patent Over Metabolic Disease Program
BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program.
Disclaimer: The following article is for informational purposes only. It does not constitute an endorsement, recommendation, or financial advice. Readers should seek professional guidance before making any investment decisions.
Real-time information is available daily at https://stockregion.net